» Eğitim Durumu

» Akademik Unvanlar

» Yayınlar

SCI-SSCI veya SCI Expanded Kapsamındaki Yayınları

  • ATIF SAYISI: 1229 H-İNDEKSİ: 19 H10 İNDEXİ: 33 (Aralık 2019)
  • Systemic inflammation and arrhythmogenesis: a review of mechanistic and clinical perspectivesmakale (Ocak 2018)
    6
    ATIF
  • Atrial fibrillation in the setting of takotsubo cardiomyopathy: Just the tip of the iceberg? Yalta K, Taylan G, Gurlertop Y. Int J Cardiol. 2018 Mar 1;254:174. doi: 10.1016/j.ijcard.2017.08.020. Epub 2018 Jan 28. No abstract
  • Soluble ST2 biomarker and reverse remodelling in patients with systolic heart failure. Yalta K, Zorkun C. Indian Heart J. 2018 Jan - Feb;70(1):196. doi: 10.1016/j.ihj.2017.11.003. Epub 2017 Nov 7. No
    1
    ATIF
  • Persistent diastolic dysfunction and its implications in the setting of takotsubo cardiomyopathy. Yalta K, Gurlertop Y, Taylan G. Int J Cardiol. 2018 Sep 1;266:40. doi: 10.1016/j.ijcard.2017.09.160. No abstract available.
    1
    ATIF
  • ft Ventricular Dysfunction in the Setting of Takotsubo Cardiomyopathy: A Review of Clinical Patterns and Practical Implications. Yalta K, Yilmaztepe M, Zorkun C. Card Fail Rev. 2018 May;4(1):14-20. doi: 10.15420/cfr.2018:24:2. Review.
    1
    ATIF
  • Mechanically expanding transcatheter aortic valves: pros and cons of a unique device technology. Yalta K, Gurdogan M, Zorkun C, Gurlertop Y. Cardiovasc Diagn Ther. 2018 Aug;8(4):538-542. doi: 10.21037/cdt.2018.04.06. No abstract available.
    1
    ATIF
  • Late coronary ischemıc syndromes assocıated wıth transcatheter aortıc valve ımplantatıon: A revıew of mechanıstıc and clınıcal aspects. Yalta K, Zorkun C, Yilmaztepe M, Gurlertop Y. Indian Heart J. 2018 Nov - Dec;70(6):901-906. doi: 10.1016/j.ihj.2018.06.015. Epub 2018 Jun 23.
    1
    ATIF
  • Aortic aneurysm in patients undergoing transcatheter aortic valve implantation: A prognostic determinant? or just an innocent bystander? Yalta K. Indian Heart J. 2018 Dec;70 Suppl 3:S501-S502. doi: 10.1016/j.ihj.2018.08.006. Epub 2018 Aug 18.
  • Neutrophil-to-lymphocyte ratio: A crucial determinant of reverse remodeling in patients with heart failure undergoing transcatheter aortic valve implantation? Yalta K. Indian Heart J. 2018 Dec;70 Suppl 3:S503-S505. doi: 10.1016/j.ihj.2018.10.413. Epub 2018 Oct 29.
  • Takotsubo cardiomyopathy and acute coronary syndromes: Are they always mutually exclusive? Yalta K, Ucar F, Yilmaztepe M, Zorkun C. Indian Heart J. 2018 Mar - Apr;70(2):326-327. doi: 10.1016/j.ihj.2017.08.006. Epub 2017 Aug 14.
    2
    ATIF
  • Turk Kardiyol Dern Ars. 2018 Jan;46(1):61-65. doi: 10.5543/tkda.2017.03256. Acute myocardial infarction shortly after valve-in-valve transcatheter aortic valve implantation successfully managedwith challenging percutaneous coronary intervention. Yalta K1, Kaya Ç, Aksoy Y, Yılmaztepe M, Kardaş F.
    3
    ATIF
  • Int J Cardiol. 2017 Sep 1;242:31-32. doi: 10.1016/j.ijcard.2017.03.082. Physically triggered takotsubo cardiomyopathy has a worse prognosis: Potential roles of systemic inflammation and coronary slow flow phenomenon. Yalta K1, Yalta T2. (Eylül 2017)
    3
    ATIF
  • Int J Cardiol. 2017 Sep 1;242:28. doi: 10.1016/j.ijcard.2017.03.008. Copeptin and its clinical implications in the setting of vasovagal syncope. Yalta K. (Eylül 2017)
  • makale (Eylül 2017)
  • makale (Eylül 2017)
  • Takotsubo Cardiomyopathy ? Acute Myocarditis ? or Both? Not so Easy to Diagnose in Certain Settings Kenan Yalta*, Mustafa Yılmaztepe, Fatih Ucar and Cafer ZorkunInt J Cardiovasc Res 6:2. doi: 10.4172/2324-8602.1000310 (Ağustos 2017)
    1
    ATIF
  • makale (Haziran 2017)
  • Indian Heart J. 2017 May - Jun;69(3):328-330. doi: 10.1016/j.ihj.2016.12.004. Epub 2017 Jan 2. Late-onset dynamic outflow tract gradient in the setting of tako-tsubo cardiomyopathy: An interesting phenomenon with potential implications? Yalta K1, Yetkin E2. (Ocak 2017)
    2
    ATIF
  • The impact of a single episode of remote ischemic preconditioning on myocardial injury after elective percutaneous coronary intervention. Yılmaztepe MA, Taylan G, Aktoz M, Gürlertop HY, Aksoy Y, Özçelik F, Yalta K, Ekuklu G. Postepy Kardiol Interwencyjnej. 2017;13(1):39-46. doi: 10.5114/aic.2017.66185. Epub 2017 Mar 10.
    3
    ATIF
  • Int J Cardiol. 2017 Sep 1;242:31-32. doi: 10.1016/j.ijcard.2017.03.082. Physically triggered takotsubo cardiomyopathy has a worse prognosis: Potential roles of systemic inflammation and coronary slow flow phenomenon. Yalta K1, Yalta T2.
  • Golden ratio: A subtle regulator in our body and cardiovascular system? makale (Ağustos 2016)
    5
    ATIF
  • makaleGolden Ratio is beating in our heart (Mart 2016)
    6
    ATIF
  • Yalta K, Yılmaztepe M, Ozkalaycı F, Ucar F.Tako-tsubo cardiomyopathy may lead to permanent changes in left ventricular geometry: Potential implications in the setting of pre-existing myocardial disease?Int J Cardiol. 2015 Oct 9;202:889-891. doi: 10.1016/j.ijcard.2015.10.022. (Ocak 2016)
    2
    ATIF
  • Yalta K, Ucar F, Yilmaztepe M, Ozkalayci F.Tako-tsubo cardiomyopathy and spontaneous coronary artery dissection: A subtle association with prognostic implications?Int J Cardiol. 2015 Aug 22;202:174-176. doi: 10.1016/j.ijcard.2015.08.152 (Ocak 2016)
    2
    ATIF
  • Int J Cardiol. 2016 Jul 1;214:107-12. doi: 10.1016/j.ijcard.2016.03.166. Epub 2016 Mar 24. Golden Ratio and the heart: A review of divine aesthetics. Yalta K1, Ozturk S2, Yetkin E3.
    7
    ATIF
  • Coronary slow flow in the setting of Tako-tsubo cardiomyopathy: A causative factor? An innocent bystander? Or a prognostic sign?Int J Cardiol. 2015 Jul 2;198:229-231. doi: 10.1016/j.ijcard.2015.06.146. [Epub ahead of print] Yalta K, Yilmaztepe M, Ucar F, Ozkalayci F. (Temmuz 2015)
  • Int J Cardiol. 2015 Mar 17;187:46-47. doi: 10.1016/j.ijcard.2015.03.174. [Epub ahead of print] Reverse remodelling in systolic heart failure: A puzzle yet to be solved? Yalta K. (Mayıs 2015)
    2
    ATIF
  • INVASIVE VERSUS CONSERVATIVE STRATEGY FOR THE MANAGEMENT OF SPONTANEOUS CORONARY ARTERY DISSECTION: WHICH IS BETTER ? Kenan YALTA, MD Mustafa YILMAZTEPE, MD Heart PUBLISHED ONLINE JULY 25 Flora OZKALAYCI, MD Nasir SIVRI, MD Bilal GEYIK, MD (Temmuz 2014)
  • The Impact of Statin Therapy on Mean Platelet Volume and its Seasonal Variation: is it Clinically Relevant?Kenan YALTA, Flora OZKALAYCI, Mustafa YILMAZTEPE, Bilal GEYIK, Nasir SIVRI, and Ertan YETKIN Int j cardiovasc res. 2014; 3: 4. (Mart 2014)
  • Tumour necrosis factor-α antagonism: a potential therapeutic target for prevention of arrhythmogenesis in the setting of acute myocardial infarction?Heart. 2014 Feb;100(3):263. Yalta K, Sivri N, Geyik B, Yetkin E. (Şubat 2014)
  • Coronary microvascular dysfunction portends poor prognosis in the setting of chronic renal failure: harnessing dual marker strategy for better risk-stratification? Int J Cardiol. 2014 Feb 1;171(2):275-6. Yalta K, Yilmaz MB. (Şubat 2014)
  • Endothelial nitric oxide synthase intron 4a/b polymorphism in coronary artery disease in Thrace region of Turkey N Sivri, A Unlu, O Palabiyik, M Budak, Y Kacmaz, K Yalta, T Sipahi Biotechnology & Biotechnological Equipment 28 (6), 1115-1120
    2
    ATIF
  • SEASONAL VARIATION IN HOSPITAL ADMISSIONS AND IN-HOSPITAL MORTALITY AMONG ELDERLY PATIENTS WITH ACUTE MYOCARDIAL INFARCTION: A SINGLE CENTRE RETROSPECTIVE ANALYSIS IN THE EUROPEAN HealthMED 2014 PART OF TURKEY Kenan YALTA, MD Flora OZKALAYCI, MD Cagdas KAYNAK, MD Nasir SIVRI, MD Meryem AKTOZ, MD Yekta GURLERTOP, MD Yuksel AKSOY, MD Fatih OZCELIK, MD HealthMED ACCEPTED IN 2013
  • Meteorologic factors may trigger arrhythmogenesis through induction of systemic inflammation and coagulation response: potential antiarrhythmic benefits of mitigating this response in arrhythmia-prone subjects under poor meteorologic conditions? Yalta K, Geyık B, Sıvrı N, Yetkın E. Int J Cardiol. 2013 Oct 12;168(5):4937-8 (Ekim 2013)
  • Statins decrease mean platelet volume irrespective of cholesterol lowering effect. Sivri N, Tekin G, Yalta K, Aksoy Y, Senen K, Yetkin E. Kardiol Pol. 2013;71(10):1042-7. doi: 10.5603/KP.2013.0259. PMID: 24197585 [PubMed - in process] (Ekim 2013)
    2
    ATIF
  • Yetkin G, Sivri N, Yalta K, Yetkin E. Golden Ratio is beating in our heart. Int J Cardiol. 2013 Oct 12;168(5):4926-7. (Ekim 2013)
  • Yalta K, Yalta T, Sivri N, Yetkin E. Copeptin and cardiovascular disease: a review of a novel neurohormone. Int J Cardiol. 2013 Sep 1;167(5):1750-9. (Eylül 2013)
    7
    ATIF
  • Sivri N, Yetkin E, Tekin GO, Yalta K, Waltenberger J. Anticoagulation in Patients With Left Ventricular Systolic Dysfunction and Sinus Rhythm: When? Clin Appl Thromb Hemost. 2013 Apr 23. [Epub ahead of print] PMID: 23615290 [PubMed - as supplied by publisher] (Nisan 2013)
  • Yilmaz, A., Erdem, A., Kucukdurmaz, Z., Karapinar, H., Gul, I., Yalta, K., Sarikaya, S., Yilmaz, M.B., Turgut, O.O., Tandogan, I. Beneficial effects of preprocedural Trimetazidine on periprocedural myocardial damage HealthMED, 2013; 7 (3), pp. 751-757. (Mart 2013)
  • Int J Cardiol. 2012 Feb 9;154(3):376-7. doi: 10.1016/j.ijcard.2011.11.045. Epub 2011 Dec 26. Serum copeptin/NT-proBNP ratio: a more reliable index of absolute endogenous stress and prognosis during the course of Tako-tsubo cardiomyopathy? Yalta K.
  • Cardiovasc J Afr. 2012 Mar;23(2):97,102. Sudden cardiac death due to β2-agonist therapy: is a genetic basis overlooked? Yalta K, Sivri N, Geyik B, Aksoy Y, Yetkin E.
  • Int J Cardiol. 2012 Jul 26;158(3):453-4. doi: 10.1016/j.ijcard.2012.05.025. Epub 2012 May 26. Headache response to nitrate in patients with coronary artery disease and systolic heart failure. Sivri N, Tekin G, Erbay AR, Yalta K, Senen K, Gür M, Yetkin E. PMID: 22633669 [PubMed - indexed for MEDLINE]
  • Balkan Med J. 2012 Sep;29(3):320-3. doi: 10.5152/balkanmedj.2012.002. Epub 2012 Sep 1. Evaluation of cardiovascular risk factors in women with uterine leimyoma: is there a link with atherosclerosis? Sivri N1, Yalta T2, Sayın C3, Yalta K1, Ozpuyan F2, Taştekin E2, Yetkin E4.
    4
    ATIF
  • Cytokines: potential contributors to arrhythmogenesis in demyelinating syndromes? Yalta K, Yalta T, Turgut OO, Yılmaz MB, Tandogan I. Int J Cardiol. 2011 Jan 7;146(1):90.
  • Extensive coronary arterial calcification: an over-adaptive phenomenon against complications of atherosclerosis? Yalta K, Yalta T, Yucel O, Sivri N. Int J Cardiol. 2011 Jan 21;146(2):227-8.
  • Insulin resistance due to statin therapy: a potential contributor to the negation of statin-induced beneficial effects on cardiac remodelling in heart failure? Yalta K. Int J Cardiol. 2011 Feb 3;146(3):417.
  • Coronary syndrome Y: should we focus more on extra-cardiac conditions including renal disease and its management? Yalta K, Yilmaz MB, Yalta T, Sivri N, Yucel O. Int J Cardiol. 2011 Feb 3;146(3):418. doi: 10.1016/j.ijcard.2010.09.039.
  • Chronotropic incompetence: an obscure cause of heart failure symptoms in survivors of critical diseases? Yalta K, Yalta T, Sıvrı N, Aksoy Y, Yetkın E. Int J Cardiol. 2011 Feb 17;147(1):171-2. doi: 10.1016/j.ijcard.2010.10.136.
  • Neuropeptide Y-induced coronary microvascular dysfunction: a significant contributor to the adverse outcomes in stress cardiomyopathy? Yalta K, Sivri N, Yalta T. Int J Cardiol. 2011 Mar 3;147(2):284. doi: 10.1016/j.ijcard.2010.09.095. Epub 2010 Dec 9. No abstract available.
    2
    ATIF
  • Int J Cardiol. 2011 Mar 17;147(3):448. doi: 10.1016/j.ijcard.2010.12.033. Epub 2010 Dec 30. Bone mineral density: a potential determinant of atherosclerotic plaque morphology in established coronary artery disease? Sivri N, Yalta T, Yalta K, Yetkin E, Aksoy Y.
  • Int J Cardiol. 2011 Apr 1;148(1):105. doi: 10.1016/j.ijcard.2010.12.068. Epub 2011 Jan 7. Copeptin (C-terminal provasopressin): a promising marker of arrhythmogenesis in arrhythmia prone subjects? Yalta K, Sıvrı N, Yalta T, Geyik B, Aksoy Y, Yetkın E.
    3
    ATIF
  • Int J Cardiol. 2011 Jun 16;149(3):383. doi: 10.1016/j.ijcard.2011.03.003. Epub 2011 Mar 24. Acute coronary syndromes in the setting of acute infections: is there an overdiagnosis with overtreatment? Yalta K, Sivri N, Yetkin E.
    1
    ATIF
  • Atherosclerosis. 2011 Nov;219(1):373-4. doi: 10.1016/j.atherosclerosis.2011.06.039. Epub 2011 Jun 25. Myocardial infarction with normal coronary arteries: role of endothelial function and vasomotion. Sivri N, Tekin GO, Yalta K, Yetkin E.
  • Int J Cardiol. 2011 Oct 6;152(1):99-100. doi: 10.1016/j.ijcard.2011.07.004. Epub 2011 Jul 31. Sahaja yoga: a unique adjunctive approach for the management of cardiac arrhythmias? Yalta K, Sivri N, Yetkin E.
  • Int J Cardiol. 2011 Dec 1;153(2):225-6. doi: 10.1016/j.ijcard.2011.09.057. Epub 2011 Oct 13. Serum ferritin: a potential determinant of myocardial ischemic burden in the setting of ischemic conditions? Yalta K, Sivri N, Yalta T, Yetkin E.
  • Geodesic pattern of coronary arteries as a predictor for cardiovascular risk: clinical perspectives. Turgut O, Tandogan I, Yalta K, Yilmaz MB, Dizman R. Int J Cardiol. 2010 Jul 23;142(3):e38-9.
  • Free-floating biatrial thrombi with concomitant saddle pulmonary embolism. Turgut O, Yalta K, Yilmaz MB, Dizman R, Tandogan I. Int J Cardiol. 2010 Sep 24;144(1):e11-3.
  • Association of P wave duration and dispersion with the risk for atrial fibrillation: practical considerations in the setting of coronary artery disease. Turgut O, Tandogan I, Yilmaz MB, Yalta K, Aydin O. Int J Cardiol. 2010 Oct 8;144(2):322-4.
    3
    ATIF
  • Natriuretic peptides: useful biomarkers in predicting the possibility of restoration and maintenance of sinus rhythm in patients with atrial fibrillation undergoing cardioversion? Yalta K, Yilmaz MB, Turgut OO, Tandogan I. Int J Cardiol. 2010 Nov 19;145(2):233;
  • Markers of inflammation and thrombin generation: additional guides in determining the therapeutic strategy for malign ventricular arrhythmias after an acute myocardial infarction? Yalta K, Yılmaz MB, Turgut OO, Tandogan I. Int J Cardiol. 2010 Dec 3;145(3):492-3.
  • Levosimendan in acute and chronic right ventricle failure. Yontar OC, Yilmaz MB, Yalta K. Acta Anaesthesiol Scand. 2010 Jan;54(1):118-9.
  • Superiority of levosimendan over dobutamine in right ventricle failure. Yontar OC, Yalta K, Yilmaz MB. Crit Care Med. 2010 Jan;38(1):342-3
  • Genetic basis of sudden cardiac death due to emotional trauma in apparently healthy individuals. Yalta K, Turgut OO, Yilmaz MB, Yilmaz A, Tandogan I. Int J Cardiol. 2010 Dec 3;145(3):518-9;
  • Triple right coronary artery accompanied by an ectopic circumflex artery arising from right sinus of Valsalva. Yalta K, Yontar OC, Yilmaz MB, Erdem A, Turgut OO, Yilmaz A, Manduz S, Tandoğan I. Anadolu Kardiyol Derg. 2010 Feb 15;10(1):E1.
  • Tako-tsubo cardiomyopathy in the setting of pre-existing myocardial disease: A potential diagnostic challenge? Yalta K, Yalta T, Sivri N, Yucel O. Int J Cardiol. 2010 Dec 3;145(3):604-5
  • Coronary slow flow: a potential prognostic marker correlating with the disease severity in renal failure? Yalta K, Yilmaz MB, Yalta T, Sivri N, Refiker M. Nephrol Dial Transplant. 2010 Sep;25(9):3124;
  • Efficacy of levosimendan in patients with chronic heart failure: Does rhythm matter? Yontar OC, Yilmaz MB, Yalta K, Tandoğan I. Anadolu Kardiyol Derg. 2010 Aug;10(4):310-6.
  • Acute effects of levosimendan and dobutamine on QRS duration in patients with heart failure. Yontar OC, Yilmaz MB, Yalta K, Erdem A, Tandogan I. Arq Bras Cardiol. 2010 Dec;95(6):738-42. Epub 2010 Nov 12
    2
    ATIF
  • Gamma-glutamyltransferase as a useful predictor for cardiovascular risk: clinical and epidemiological perspectives. Turgut O, Yilmaz MB, Yalta K, Tandogan I. Atherosclerosis. 2009 Feb;202(2):348-9.
  • Prognostic relevance of coronary collateral circulation: clinical and epidemiological implications. Turgut O, Yilmaz MB, Yalta K, Tandogan I, Yilmaz A. Int J Cardiol. 2009 Nov 12;137(3):300-1.
  • Crimean-Congo hemorrhagic fever: does it involve the heart? Engin A, Yilmaz MB, Elaldi N, Erdem A, Yalta K, Tandogan I, Kaya S, Bakir M, Dokmetas I. Int J Infect Dis. 2009 May;13(3):369-73.
  • Comparative effects of levosimendan and dobutamine on right ventricular function in patients with biventricular heart failure. Yilmaz MB, Yontar C, Erdem A, Karadas F, Yalta K, Turgut OO, Yilmaz A, Tandogan I. Heart Vessels. 2009 Jan;24(1):16-21.
    4
    ATIF
  • Coronary flow slows as renal function worsens. Yilmaz MB, Yalta K. Clin Cardiol. 2009 May;32(5):278-82
    1
    ATIF
  • Evaluation of myocardial viability with thallium-201 infusion MPSPECT after oral glucose application in patients with chronic coronary artery disease. Hasbek Z, Turgut B, Erselcan T, Yalta K, Tandogan I, Ozer G, Ozdemir U, Turgut NH. Nucl Med Commun. 2009 Oct;30(10):779-88.
  • Dronedarone: a promising alternative for the management of atrial fibrillation. Yalta K, Turgut OO, Yilmaz MB, Yilmaz A, Tandogan I. Cardiovasc Drugs Ther. 2009 Oct;23(5):385-93. doi: 10.1007/s10557-009-6189-0. Review.
  • Acute heart failure and near-syncope associated with giant left atrial ball thrombus occluding left ventricular inflow tract. Yalta K, Yilmaz A, Turgut OO, Yilmaz MB, Karadas F, Bektasoglu G, Tandogan I. Eur J Echocardiogr. 2008 Jan;9(1):86-7.
  • Reduced repolarization reserve: An important but not the unique predictor of drug induced fatal ventricular arrhythmia. Yalta K, Yilmaz A, Turgut OO, Yilmaz MB. Int J Cardiol. 2008; 124: 368-369.
  • Initial syncope associated with alternating attacks of supraventricular tachycardia and atrioventricular block long after surgical correction of tricuspid atresia. Yalta K, Yontar C, Karadas F, Yilmaz MB, Turgut OO, Yilmaz A, Erdem A, Tandogan I. Cardiol J. 2008;15(2):186-8.
  • Impact of beta-blockers on sleep in patients with mild hypertension: a randomized trial between nebivolol and metoprolol. Yilmaz MB, Erdem A, Yalta K, Turgut OO, Yilmaz A, Tandogan I. Adv Ther. 2008 Sep;25(9):871-83.
    1
    ATIF
  • Short QT syndrome: a very rare arrhythmogenic entity. Yontar OC, Yalta K, Yilmaz MB, Turgut OO. Acta Cardiol. 2008 Oct;63(5):553-5. Review.
  • Left ventricular outflow tract myxoma accompanied by dextrocardia with situs inversus: a case report. Yalta K, Turgut OO, Yilmaz A, Yilmaz MB, Ozyol A, Karadas F, Tandogan I. Int J Cardiovasc Imaging. 2007 Jun;23(3):329-32.
  • Torsades de pointes with a severely prolonged QT interval induced by an initial low dose sotalol intake. Yalta K, Turgut O, Yilmaz A, Yilmaz MB, Kendirlioglu O, Karadas F. Int J Cardiol. 2007 Apr 4;116(3):e95-7.
    2
    ATIF
  • Herbals in cardiovascular practice: are physicians neglecting anything? Yilmaz MB, Yontar OC, Turgut OO, Yilmaz A, Yalta K, Gul M, Tandogan I. Int J Cardiol. 2007 Oct 31;122(1):48-51.
    2
    ATIF
  • Tortuosity of coronary arteries: an indicator for impaired left ventricular relaxation? Turgut O, Yilmaz A, Yalta K, Yilmaz BM, Ozyol A, Kendirlioglu O, Karadas F, Tandogan I. Int J Cardiovasc Imaging. 2007 Dec;23(6):671-7.
    7
    ATIF
  • The effect of collateral circulation on left ventricular systolic function. Karadas F, Yalta K, Turgut OO, Yilmaz MB, Yilmaz A, Dogan K, Tandogan I. Coron Artery Dis. 2007 May;18(3):169-73.
  • Acute coronary syndrome: short-term effects of early intravenous metoprolol on maximum P wave duration and P wave dispersion. Turgut O, Yilmaz MB, Yilmaz A, Yalta K, Kendirlioglu O, Tandogan I. Adv Ther. 2007 Jan-Feb;24(1):14-22.
  • The left anterior descending artery arising from the right sinus of Valsalva: a case report. Yilmaz A, Yalta K, Turgut OO, Yilmaz MB, Karadas F, Erdem A, Ozyol A, Tandogan I. Adv Ther. 2007 Jan-Feb;24(1):178-81.
  • Heart rate turbulence: an additional parameter in determining the need for mechanical relief of mitral stenosis? Yalta K, Erdem A, Yilmaz A, Turgut OO, Yilmaz MB, Yontar C, Tandogan I. J Heart Valve Dis. 2007 May;16(3):255-9.
  • Asymptomatic total anomalous pulmonary venous connection with double drainage in a young adult: a case report. Yalta K, Turgut OO, Yilmaz A, Yilmaz MB, Manduz S, Karadas F, Dogan K, Tandogan I. Heart Surg Forum. 2007;10(3):E211-2.
  • Sleep quality among relatively younger patients with initial diagnosis of hypertension: dippers versus non-dippers. Yilmaz MB, Yalta K, Turgut OO, Yilmaz A, Yucel O, Bektasoglu G, Tandogan I. Blood Press. 2007;16(2):101-5.
    6
    ATIF
  • The severity of ST segment elevation in acute inferior myocardial infarction: does it predict the presence of a proximal culprit lesion along the right coronary artery course? Erdem A, Yilmaz MB, Yalta K, Turgut OO, Tandoğan I. Anadolu Kardiyol Derg. 2007 Jul;7 Suppl 1:189-90.
  • Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine. Yilmaz MB, Yalta K, Yontar C, Karadas F, Erdem A, Turgut OO, Yilmaz A, Tandogan I. Cardiovasc Drugs Ther. 2007 Dec;21(6):431-5.
  • Comparison of myocardial performance index versus ratio of isovolumic contraction time/ejection time in left ventricular systolic dysfunction. Yilmaz A, Yalta K, Turgut OO, Yilmaz MB, Ozyol A, Erdem A, Tandogan I. Adv Ther. 2007 Sep-Oct;24(5):1061-7.
  • Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine. Yilmaz MB, Yalta K, Yontar C, Karadas F, Erdem A, Turgut OO, Yilmaz A, Tandogan I. Cardiovasc Drugs Ther. 2007 Dec;21(6):431-5.
    4
    ATIF
  • The effect of smoking on cardiac diastolic parameters including Vp, a more reliable and newer parameter. Yilmaz A, Yalta K, Turgut OO, Yilmaz MB, Erdem A, Karadas F, Ozyol A, Tandogan I. Cardiol J. 2007;14(3):281-6.
  • gamma-Glutamyltransferase is a promising biomarker for cardiovascular risk. Turgut O, Yilmaz A, Yalta K, Karadas F, Birhan Yilmaz M. Med Hypotheses. 2006;67(5):1060-4. Epub 2006 Aug 7. Review.
    3
    ATIF
  • Evaluation of tumor markers CA-125 and CEA in acute myocardial infarction. Yalta K, Yilmaz A, Turgut OO, Erselcan T, Yilmaz MB, Karadas F, Yontar C, Tandogan I. Adv Ther. 2006 Nov-Dec;23(6):1052-9.
    3
    ATIF
  • Clinical importance of elevated CK-MB and troponin I levels in congestive heart failure. Yilmaz A, Yalta K, Turgut OO, Yilmaz MB, Ozyol A, Kendirlioglu O, Karadas F, Tandogan I. Adv Ther. 2006 Nov-Dec;23(6):1060-7.
    5
    ATIF
  • Relationship between control of ventricular rate in atrial fibrillation and systemic coagulation activation in patients with mitral stenosis. Atak R, Turhan H, Senen K, Yalta K, Ayaz S, Alyan O, Basar N, Demirkan D. J Heart Valve Dis. 2004 Mar;13(2):159-64.
  • derleme

Uluslararası Hakemli Dergilerde Yayınlanan Makaleler

  • Yalta K, Yılmaztepe M, Ozkalaycı F, Ucar F.Tako-tsubo cardiomyopathy may lead to permanent changes in left ventricular geometry: Potential implications in the setting of pre-existing myocardial disease?Int J Cardiol. 2015 Oct 9;202:889-891. doi: 10.1016/j.ijcard.2015.10.022. (Ekim 2016)
  • Int J Cardiol. 2016 Jul 1;214:107-12. doi: 10.1016/j.ijcard.2016.03.166. Epub 2016 Mar 24. Golden Ratio and the heart: A review of divine aesthetics. Yalta K1, Ozturk S2, Yetkin E3.

Editörlük / Yayınlama

  • BALKAN MEDICAL JOURNAL SAYI 4
  • BALKAN MEDICAL JOURNAL SAYI 3
  • BALKAN MEDICAL JOURNAL SAYI 2
  • BALKAN MEDICAL JOURNAL SAYI 1
  • BALKAN MEDICAL JOURNAL
  • BALKAN MEDICAL JOURNAL

Yapılan Hakemlikler

  • BALKAN MEDICAL JOURNAL
  • BALKAN MEDICAL JOURNAL
  • BALKAN MEDICAL JOURNAL
  • BALKAN MEDICAL JOURNAL
  • TKD ARŞİV
  • Journal of Neurocardiovascular Diseases
  • ANADOLU KARDİYOLOJİ DERGİSİ (11 ADET)
  • TKD ARŞİV
  • TKD ARŞİV

Ödüller

  • 2008 YAYIN ÖDÜLÜ
  • 2007 YAYIN ÖDÜLÜ
  • 2006 YAYIN ÖDÜLÜ